MORE►
Renibus Therapeutics
Renibus Therapeutics CEO Jeff Keyser [Composite photo; original: Renibus Therapeutics]
BioNTX To Honor Renibus Therapeutics CEO with its 2024 Dennis K. Stone Award at iC³ Conference
by Lance Murray | Oct 2, 2024
Renibus CEO Jeff Keyser will be acknowledged as the award recipient at the 10th Annual iC³ Life Science & Healthcare Innovation Summit on Thursday, the first day of the Oct. 3-4 summit at the Loews Arlington Hotel & Convention Center.
by Lance Murray |
Dec 8, 2022
Southlake-based Renibus Therapeutics—a clinical-stage biotech company developing innovative products for cardiorenal diseases—has received $33 million in bridge financing to help it advance three drugs in its pipeline. The drugs are currently in various phases of trials.
MORE►
by Kevin Cummings |
Aug 29, 2022
In this week’s North Texas deal flow, you’ll also find news about Biotech Renibus Therapeutics raising $8.48M to fight cardio-renal disease; Deposits raising $5M for its plug-and-play financial services platform; Lion Real Estate Group targeting multifamily properties in the Sun Belt with a $200M fund, and more.
MORE►
by Kevin Cummings |
Aug 8, 2022
Plus: 7-Eleven acquires last-mile delivery startup; American Heart Association invests in $43M healthcare innovation fund; Fort Worth real estate investors raise $32.4M for new fund; Dallas College Lands $8.8M to boost biotech workforce; UT Southwestern researchers land funding for hypothermia therapy study; and more North Texas deals.
MORE►
DI People: Addverb, Renibus Therapeutics, Denton EDP, Fort Worth Executive Roundtable, RumbleOn, and More Make Moves
by Dallas Innovates | Staff Report | Feb 18, 2022
In this week's roundup of hires, promotions, and accolades in North Texas, you'll also find news from VERTESS, Mr. Cooper, Active Cyber, EarthX, SWK Holdings, and more.
Plus, Fort Worth Mayor Mattie Parker makes an appointment to the city council's Entrepreneurship and Innovation Committee.
Plus, Fort Worth Mayor Mattie Parker makes an appointment to the city council's Entrepreneurship and Innovation Committee.
MORE►
by Kevin Cummings |
Feb 16, 2022
Renibus Therapeutics, which focuses on treatments for acute and chronic kidney diseases, announced closing a $35 million Series A funding round. Its new CEO, Frank Stonebanks, says "Renibus has arrived at a critical inflection point in its commitment to transform the prevention and treatment of kidney diseases."
MORE►
by Lance Murray |
Sep 26, 2019
In this weekly roundup of funding, merger, and acquisition activity involving companies in North Texas, you’ll also find news about Fetch, Figable, Stealth Monitoring, Solo Stove, BP Energy Partners, Integrity Marketing, a360inc, and more.
MORE►
